Patents by Inventor Wajdie Ahmad

Wajdie Ahmad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20230027850
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures.
    Type: Application
    Filed: February 28, 2022
    Publication date: January 26, 2023
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20220395561
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: March 30, 2022
    Publication date: December 15, 2022
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20220370574
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: March 23, 2022
    Publication date: November 24, 2022
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
    Publication number: 20220226446
    Abstract: Disclosed herein are compositions and methods for use in reducing lung function inhibition.
    Type: Application
    Filed: December 2, 2021
    Publication date: July 21, 2022
    Inventors: Fauad Hasan, Wajdie Ahmad, Sawsan Abushakra
  • Botulinum neurotoxins for use in therapy
    Patent number: 11260114
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: March 1, 2022
    Assignee: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20210106660
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 15, 2021
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20200046814
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Application
    Filed: March 22, 2018
    Publication date: February 13, 2020
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING TRAUMATIC INJURIES
    Publication number: 20200023044
    Abstract: Disclosed herein are compositions and methods for use in treating injuries.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 23, 2020
    Applicant: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20190183987
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
    Publication number: 20190125844
    Abstract: Disclosed herein are compositions and methods for use in reducing lung function inhibition.
    Type: Application
    Filed: November 1, 2018
    Publication date: May 2, 2019
    Inventors: Fauad Hasan, Wajdie Ahmad, Sawsan Abushakra